Antithrombotic Treatment in Antiphospholipid Syndrome: A Review
Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by circulating autoantibodies that recognize cell surface phospholipids and phospholipid-binding proteins. APS is an autoimmune disorder associated with recurrent thrombosis of arterial or venous vessels and/or recurrent obs...
Saved in:
| Main Authors: | Carmine Siniscalchi, Francesca Futura Bernardi, Pierpaolo Di Micco, Alessandro Perrella, Tiziana Meschi, Ugo Trama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Immuno |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-5601/4/4/36 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct-acting oral anticoagulants in antiphospholipid syndrome
by: T. M. Reshetnyak, et al.
Published: (2021-01-01) -
Prospective study of perinatal outcome in pregnancies with primary antiphospholipid syndrome
by: Ćetković Aleksandar, et al.
Published: (2014-01-01) -
PREVENTION OF THROMBOSES IN ANTIPHOSPHOLIPID SYNDROME
by: Lyubov Valeryevna Kondratyeva, et al.
Published: (2009-09-01) -
Strategies of anticoagulant therapy in various clinical variants of antiphospholipid syndrome
by: A. A. Klimenko, et al.
Published: (2024-06-01) -
Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2023-10-01)